etoposide has been researched along with bilirubin in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.00) | 18.7374 |
| 1990's | 6 (30.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Aoki, K; Nose, H; Okada, S; Okazaki, N; Yoshimori, M | 1 |
| Arbuck, SG; Evans, WE; Fleming, RA; Stewart, CF | 3 |
| Arbuck, SG; Fleming, RA; Stewart, CF | 1 |
| Arbuck, SG; Evans, WE; Pieper, JA; Stewart, CF | 1 |
| Arbuck, SG; Cooper, C; Crom, WR; Douglass, HO; Evans, WE; Goodwin, P; Silk, Y | 1 |
| Lim, CK; Peters, TJ | 1 |
| Aita, P; Boiocchi, M; Cannizzaro, R; Colussi, AM; Corona, G; Robieux, I; Sorio, R; Toffoli, G; Tumolo, S | 1 |
| Adjei, AA; Creagan, ET; Croghan, G; Frytak, S; Giordano, KF; Jatoi, A; Jett, JR; Marks, R; Molina, J; Okuno, S; Richardson, RL | 1 |
| Ali, SY; Smith, PC; Tallman, MN; Wen, Z | 1 |
| Desai, AA; Fleming, GF; House, L; Innocenti, F; Kobayashi, K; Ramirez, J; Ratain, MJ; Schilsky, RL; Shepard, D; Vogelzang, NJ; Yong, WP | 1 |
| Becker, H; Lübbert, M; Schäfer, HS; Schmitt-Gräff, A | 1 |
| Asano, T; Ishii, E; Kanegane, H; Kogawa, K; Kudo, K; Morimoto, A; Oda, M; Ohga, S; Ohta, S; Sato, H; Wakiguchi, H | 1 |
| Aumont, C; Coppo, P; Fardet, L; Galicier, L; Lambotte, O; Marzac, C; Rivière, S | 1 |
| Bachy, E; Casasnovas, O; Freyer, G; Guitton, J; Hénin, E; Ribrag, V; Salles, G; Sebban, C; Tilly, H; Tod, M; You, B | 1 |
| Mansour, DS; Morsi, RM; Mousa, AM | 1 |
1 review(s) available for etoposide and bilirubin
| Article | Year |
|---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
2 trial(s) available for etoposide and bilirubin
| Article | Year |
|---|---|
Pharmacokinetic modulation of oral etoposide by ketoconazole in patients with advanced cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents, Phytogenic; Area Under Curve; Bilirubin; Dose-Response Relationship, Drug; Drug Interactions; Etoposide; Fatigue; Female; Humans; Ketoconazole; Male; Middle Aged; Neutropenia | 2007 |
Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group.
Topics: Adrenal Cortex Hormones; Age of Onset; Antineoplastic Agents, Phytogenic; Asian People; Bilirubin; Child; Child, Preschool; Cyclosporine; Data Collection; Disease-Free Survival; Epstein-Barr Virus Infections; Etoposide; Herpesvirus 4, Human; Humans; Hyperbilirubinemia; Immunosuppressive Agents; Infant; Japan; Lymphohistiocytosis, Hemophagocytic; Remission Induction; Retrospective Studies; Survival Rate | 2014 |
17 other study(ies) available for etoposide and bilirubin
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy.
Topics: alpha-Fetoproteins; Analysis of Variance; Antineoplastic Agents; Ascites; Bilirubin; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Interferon-gamma; Liver Neoplasms; Male; Middle Aged; Mitoxantrone; Multivariate Analysis; Prognosis; Regression Analysis; Risk Factors; Serum Albumin; Tegafur; Time Factors | 1992 |
Factors affecting in vitro protein binding of etoposide in humans.
Topics: Bilirubin; Blood Proteins; Drug Stability; Etoposide; Heparin; Humans; Hydrogen-Ion Concentration; Orosomucoid; Protein Binding; Serum Albumin | 1992 |
Interspecies differences in in vitro etoposide plasma protein binding.
Topics: Animals; Bilirubin; Blood Proteins; Cats; Dogs; Etoposide; Humans; Mice; Mice, Inbred Strains; Protein Binding; Rabbits; Rats; Rats, Inbred Strains; Sheep; Species Specificity | 1991 |
Prospective evaluation of a model for predicting etoposide plasma protein binding in cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Bilirubin; Blood Proteins; Etoposide; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Models, Biological; Neoplasms; Prospective Studies; Protein Binding; Serum Albumin | 1990 |
Changes in the clearance of total and unbound etoposide in patients with liver dysfunction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Chromatography, High Pressure Liquid; Cisplatin; Creatinine; Etoposide; Female; Humans; Liver; Liver Function Tests; Male; Neoplasms; Protein Binding; Regression Analysis | 1990 |
Altered protein binding of etoposide in patients with cancer.
Topics: Adult; Aged; Bilirubin; Blood Proteins; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms; Protein Binding; Serum Albumin | 1989 |
Etoposide pharmacokinetics in patients with normal and abnormal organ function.
Topics: Adult; Aged; Bile; Bilirubin; Chromatography, High Pressure Liquid; Creatinine; Etoposide; Female; Humans; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Urine | 1986 |
Ammonium acetate: a general purpose buffer for clinical applications of high-performance liquid chromatography.
Topics: Acetates; Bilirubin; Biogenic Amines; Buffers; Catecholamines; Chromatography, High Pressure Liquid; Creatinine; Etoposide; Porphyrins; Retinoids; Teniposide; Verapamil | 1984 |
Pharmacokinetics of oral etoposide in patients with hepatocellular carcinoma.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Aspartate Aminotransferases; Bilirubin; Biological Availability; Blood Proteins; Carcinoma, Hepatocellular; Chromatography, High Pressure Liquid; Etoposide; Humans; Lidocaine; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Metabolic Clearance Rate; Middle Aged; Protein Binding; Serum Albumin; Ultrafiltration | 1999 |
Ramifications of severe organ dysfunction in newly diagnosed patients with small cell lung cancer: contemporary experience from a single institution.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Carboplatin; Carcinoma, Small Cell; Cisplatin; Creatinine; Cyclophosphamide; Decision Making; Etoposide; Female; Humans; Lung Neoplasms; Male; Medical Records; Middle Aged; Multiple Organ Failure; Neoplasm Staging; Paclitaxel; Platelet Count; Survival Rate; Treatment Outcome | 2005 |
UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for etoposide glucuronidation in human liver and intestinal microsomes: structural characterization of phenolic and alcoholic glucuronides of etoposide and estimation of enzyme kinetics.
Topics: Alcohols; Antineoplastic Agents, Phytogenic; Bilirubin; Estradiol; Ethinyl Estradiol; Etoposide; Glucuronides; Glucuronosyltransferase; Humans; Intestinal Mucosa; Kinetics; Liver; Microsomes; Phenols | 2007 |
Granulocytic sarcoma of Core-binding Factor (CBF) acute myeloid leukemia mimicking pancreatic cancer.
Topics: Aged; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; CA-19-9 Antigen; Carboplatin; Core Binding Factors; Diagnosis, Differential; Etoposide; Female; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Lipase; Magnetic Resonance Imaging; Pancreatic Neoplasms; Sarcoma, Myeloid | 2008 |
Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Aspartate Aminotransferases; Bilirubin; C-Reactive Protein; Etoposide; Female; Ferritins; Fever; France; Glucocorticoids; Hemoglobins; Humans; Immunocompromised Host; L-Lactate Dehydrogenase; Leukocyte Count; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Male; Middle Aged; Multiple Organ Failure; Platelet Count; Retrospective Studies; Sodium; Triglycerides | 2014 |
Etoposide pharmacokinetics impact the outcomes of lymphoma patients treated with BEAM regimen and ASCT: a multicenter study of the LYmphoma Study Association (LYSA).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Carmustine; Creatinine; Cytarabine; Disease-Free Survival; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Serum Albumin; Transplantation, Autologous; Treatment Outcome; Young Adult | 2015 |
Ameliorative potential role of Rosmarinus officinalis extract on toxicity induced by etoposide in male albino rats.
Topics: Albumins; Animals; Antioxidants; Bilirubin; Etoposide; Hydrogen Peroxide; NF-E2-Related Factor 2; Nitric Oxide; Oxidative Stress; Plant Extracts; Rats; Rosmarinus; Superoxide Dismutase | 2022 |